HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sunscreen Industry Asks FDA For Flexibility Despite Guidances' Rigidity

This article was originally published in The Rose Sheet

Executive Summary

FDA latest sunscreen guidances incorporate little industry input and are met with frustration and hope among industry stakeholders. The PASS Coalition and the Natural Products Association weigh in on future cooperation between FDA and industry under SIA.

Advertisement

Related Content

Toxicity Testing For Topical Drugs, Sunscreens Included, On Tap In US FDA Workshop
Toxicity Testing For Topical Drugs, Sunscreens Included, On Tap In US FDA Workshop
Toxicity Testing For Topical Drugs, Sunscreens Included, On Tap In US FDA Workshop
FDA Sunscreen Guidance: Absorption Data Is A MUsT For GRASE Review
Sunscreen Group Remains Cloudy About FDA's Ingredient Evaluations
NPA Seeks Clarified FDA Guidance On OTC Sunscreen Ingredient Review

Topics

Advertisement
UsernamePublicRestriction

Register

RS108703

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel